536 related articles for article (PubMed ID: 26935094)
1. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M
Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS.
Ando G; Taguchi K; Enoki Y; Yokoyama Y; Kizu J; Matsumoto K
Biol Pharm Bull; 2019; 42(11):1799-1804. PubMed ID: 31685764
[TBL] [Abstract][Full Text] [Related]
3. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
Nagai J; Ishikawa Y
PLoS One; 2021; 16(12):e0260980. PubMed ID: 34855908
[TBL] [Abstract][Full Text] [Related]
4. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
5. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
6. Blood Pressure Elevation Associated with Topical Prostaglandin F2α Analogs: An Analysis of the Different Spontaneous Adverse Event Report Databases.
Ohyama K; Kawakami H; Inoue M
Biol Pharm Bull; 2017; 40(5):616-620. PubMed ID: 28458346
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases.
Mukai R; Hasegawa S; Umetsu R; Nakao S; Shimada K; Uranishi H; Masuta M; Suzuki H; Nishibata Y; Nakamura M
J Clin Pharm Ther; 2019 Apr; 44(2):285-291. PubMed ID: 30569470
[TBL] [Abstract][Full Text] [Related]
8. Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database.
Shimada K; Hasegawa S; Nakao S; Mukai R; Sasaoka S; Ueda N; Kato Y; Abe J; Mori T; Yoshimura T; Kinosada Y; Nakamura M
Int J Med Sci; 2019; 16(9):1295-1303. PubMed ID: 31588196
[TBL] [Abstract][Full Text] [Related]
9. Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
Fahim SM; Mishuk AU; Cheng N; Hansen R; Calderón AI; Qian J
Expert Opin Drug Saf; 2019 Feb; 18(2):145-152. PubMed ID: 30576263
[TBL] [Abstract][Full Text] [Related]
10. Analysis of drug-induced hand-foot syndrome using a spontaneous reporting system database.
Yoshida Y; Sasaoka S; Tanaka M; Matsumoto K; Inoue M; Satake R; Shimada K; Mukai R; Suzuki T; Iwata M; Goto F; Mori T; Mori K; Yoshimura T; Nakamura M
Ther Adv Drug Saf; 2022; 13():20420986221101963. PubMed ID: 35646307
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Chisaki Y; Aoji S; Yano Y
Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
[TBL] [Abstract][Full Text] [Related]
12. Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis.
Anzai T; Takahashi K; Watanabe M; Mochizuki M; Murashima A
BMC Psychiatry; 2020 Mar; 20(1):118. PubMed ID: 32164630
[TBL] [Abstract][Full Text] [Related]
13. [Methodology for Estimating the Risk of Adverse Drug Reactions in Pregnant Women: Analysis of the Japanese Adverse Drug Event Report Database].
Sakai T; Ohtsu F; Sekiya Y; Mori C; Sakata H; Goto N
Yakugaku Zasshi; 2016; 136(3):499-505. PubMed ID: 26935093
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).
Wittayanukorn S; Qian J; Johnson BS; Hansen RA
J Oncol Pharm Pract; 2017 Mar; 23(2):93-102. PubMed ID: 26661047
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database.
Nakao S; Hatahira H; Sasaoka S; Hasegawa S; Motooka Y; Ueda N; Abe J; Fukuda A; Naganuma M; Kanoh H; Seishima M; Ishiguro M; Kinosada Y; Nakamura M
Biol Pharm Bull; 2017; 40(12):2158-2165. PubMed ID: 29199239
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy in three different spontaneous adverse drug event databases.
Mabuchi T; Hosomi K; Yokoyama S; Takada M
Int J Clin Pharmacol Ther; 2020 Nov; 58(11):601-607. PubMed ID: 32729825
[TBL] [Abstract][Full Text] [Related]
17. Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS).
Rahman MM; Alatawi Y; Cheng N; Qian J; Peissig PL; Berg RL; Page DC; Hansen RA
Clin Drug Investig; 2017 Dec; 37(12):1143-1152. PubMed ID: 28933038
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors.
Verden A; Dimbil M; Kyle R; Overstreet B; Hoffman KB
Drug Saf; 2018 Apr; 41(4):357-361. PubMed ID: 29196988
[TBL] [Abstract][Full Text] [Related]
19. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases.
Nomura K; Takahashi K; Hinomura Y; Kawaguchi G; Matsushita Y; Marui H; Anzai T; Hashiguchi M; Mochizuki M
Drug Des Devel Ther; 2015; 9():3031-41. PubMed ID: 26109846
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
